
Home » FDA RESTARTS REVIEW OF ENTEREG
FDA RESTARTS REVIEW OF ENTEREG
May 31, 2006
Pharmaceutical companies Adolor Corp. and GlaxoSmithKline Plc on Wednesday said regulators will resume reviewing the companies' application for a drug to treat intestinal obstructions after new data from a study reaffirmed the drug's effectiveness.
Business Week
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr